TrialClinical pharmacokinetics2006

Lack of pharmacokinetic interaction for ISIS 113715, a 2'-0-methoxyethyl modified antisense oligonucleotide targeting protein tyrosine phosphatase 1B messenger RNA, with oral antidiabetic compounds metformin, glipizide or rosiglitazone.

Richard S Geary et al.PubMed ↗Publisher ↗

No numbers read from the abstract.